|1.||Horiuchi, Masatsugu: 15 articles (12/2015 - 05/2003)|
|2.||Unger, Thomas: 11 articles (05/2015 - 04/2005)|
|3.||Mogi, Masaki: 10 articles (12/2015 - 09/2005)|
|4.||Widdop, Robert E: 10 articles (09/2014 - 03/2005)|
|5.||Iwanami, Jun: 8 articles (12/2015 - 09/2008)|
|6.||Tsukuda, Kana: 8 articles (12/2015 - 09/2008)|
|7.||Sumners, Colin: 7 articles (10/2014 - 11/2004)|
|8.||Min, Li-Juan: 7 articles (08/2014 - 09/2005)|
|9.||Iwai, Masaru: 7 articles (12/2009 - 05/2003)|
|10.||Steckelings, U Muscha: 6 articles (06/2014 - 12/2008)|
|1.||Neuralgia (Stump Neuralgia)
01/01/2015 - "Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies."
05/01/2013 - "The objective of this study was to define the pharmacokinetics, oral bioavailability, and efficacy in rats of small molecule antagonists of the angiotensin II type 2 receptor (AT₂R) for the relief of neuropathic pain. "
02/01/2015 - "Angiotensin II type 2-receptor: new clinically validated target in the treatment of neuropathic pain."
10/01/2014 - "Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain."
05/10/2014 - "The angiotensin II type 2 receptor (AT2R) is a new target for neuropathic pain. "
03/01/2008 - "In this study, we assess whether AT1 antagonists and angiotensin II type 2 receptor (AT2) antagonists can suppress the hepatic fibrosis and lipid peroxidation in CDD rats that lead to the development of NASH. "
11/01/2015 - "Inhibitory experiments revealed that lacrimal gland fibrosis was suppressed in mice treated with an AT1R blocker, but not in mice treated with an angiotensin II type 2 receptor blocker. "
02/01/2012 - "In summary, angiotensin-(1-9) reduced cardiac fibrosis and altered aortic contraction via the angiotensin type 2 receptor supporting a direct role for angiotensin-(1-9) in the renin-angiotensin system."
02/01/2009 - "Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis."
03/01/2004 - "We speculate that the beneficial effect of the angiotensin II type 2 receptor blocker is due to a reduction in radiation-induced renal cell proliferation or fibrosis."
02/01/2012 - "Previously, compound 21, a selective nonpeptide angiotensin II type 2 receptor agonist improved the outcome of myocardial infarction in rats along with anti-inflammatory properties. "
06/01/2014 - "Effects of cardiac overexpression of the angiotensin II type 2 receptor on remodeling and dysfunction in mice post-myocardial infarction."
04/01/2012 - "Cardiac overexpression of the angiotensin II type 2 receptor (AT2 R) attenuates left ventricular (LV) remodeling after myocardial infarction (MI) in transgenic mice. "
02/01/2012 - "Compound 21 (C21), a selective angiotensin type 2 receptor agonist, has demonstrated beneficial effects on cardiac function after myocardial infarction in rodents. "
12/09/2008 - "Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?"
08/01/2014 - "Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage."
01/01/2015 - "Angiotensin II type 2 receptor (AT2R) stimulation is neuroprotective after experimental stroke. "
12/01/2012 - "Angiotensin II type 2 receptor agonists as therapies for ischemic stroke."
12/01/2012 - "We have demonstrated previously that pretreatment with an angiotensin II type 2 receptor (AT(2)R) agonist is neuroprotective against a subsequent stroke independent of any changes in blood pressure. "
12/01/2012 - "Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats."
10/01/2013 - "Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion."
07/01/2008 - "Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain."
04/01/2007 - "Angiotensin II type 2 receptor decreases ischemia reperfusion induced fluid leak."
05/31/2002 - "Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb."
09/01/2008 - "Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice."
|1.||Matrix Metalloproteinase 1 (Interstitial Collagenase)
|2.||Matrix Metalloproteinase 9 (Gelatinase B)
|3.||NADPH Oxidase (NAD(P)H oxidase)
|4.||Transforming Growth Factors (Transforming Growth Factor)
|6.||Type 1 Angiotensin Receptor
|8.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)